High-quality NMR structure of human anti-apoptotic protein domain Mcl-1(171-327) for cancer drug design.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24789074.
- Also identified by DOI 10.1371/journal.pone.0096521 and PMC identifier 4008586.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A high-quality NMR solution structure is presented for protein hMcl-1(171-327) which comprises residues 171-327 of the human anti-apoptotic protein Mcl-1 (hMcl-1). Since this construct contains the three Bcl-2 homology (BH) sequence motifs which participate in forming a binding site for inhibitors of hMcl-1, it is deemed to be crucial for structure-based design of novel anti-cancer drugs blocking the Mcl1 related anti-apoptotic pathway. While the coordinates of an NMR solution structure for a corresponding construct of the mouse homologue (mMcl-1) are publicly available, our structure is the first atomic resolution structure reported for the 'apo form' of the human protein. Comparison of the two structures reveals that hMcl-1(171-327) exhibits a somewhat wider ligand/inhibitor binding groove as well as a different charge distribution within the BH3 binding groove. These findings strongly suggest that the availability of the human structure is of critical importance to support future design of cancer drugs.
Medical subject headings
- Magnetic Resonance Spectroscopy
- Myeloid Cell Leukemia Sequence 1 Protein
- Peptide Fragments
- Protein Structure, Tertiary